A Shift Beneath the Total

A company developing a new food ingredient, a startup using AI to cut restaurant waste, and a service making nutrition more personal to the individual can all sit under the same "foodtech" label — and compete for the same investor's attention. All three are reshaping our relationship with food, but their capital needs, their path to market, and their ability to generate revenue look nothing alike.

PitchBook's H1 2026 Foodtech report lays those differences out clearly. Total funding is down, but specific categories are still pulling in large rounds. Exits are improving, but most of that improvement traces back to a single transaction. And food innovation itself hasn't stopped — it just requires a sharper read than a simple boom-or-bust framing.

Less Capital, but Deals Aren't Necessarily Smaller

Global venture investment in foodtech reached $3.6 billion across 359 deals in H1 2026, down from $4 billion across 493 deals in the same period a year earlier. Deal count fell faster than total value. Compared with 2022, median deal size climbed from $2.2 million to a record $4.3 million in H1 2026, with the report pointing to greater concentration of capital in later-stage rounds.

The picture, then, isn't an even retreat across every company. There are fewer deals overall, but the companies that do succeed in raising are able to secure larger rounds. The report cautions against reading too much into any single quarterly dip — part of Q2's decline versus Q1 reflects the absence of the kind of outsized deals that marked the start of the year.

The more useful question isn't whether investor interest in foodtech has ended. It's what investors have become more willing to fund within it.

Personalized Nutrition Pulls Ahead

One of the clearest answers comes from personalized nutrition — the category the report's analyst appears most optimistic about. It raised roughly $256 million across 12 deals in Q2 alone, already surpassing its full-year 2025 total of $185 million. Notable rounds included Nourish at $100 million and Ultrahuman at $81 million.

The analyst ties the category's appeal to recurring revenue, software-like economics, and demand accelerated in part by the spread of GLP-1 weight-loss medications. What's worth pausing on isn't the funding total alone — a meaningful share of investment in the future of food is flowing toward an ongoing relationship with the individual: understanding their needs, tracking their behavior, helping them make decisions about their own nutrition.

AI Enters Through Operations

If personalized nutrition is moving closer to the individual, a large share of AI activity is moving closer to the everyday problems of food businesses. The report tracks activity in demand forecasting and waste reduction at companies like Freshflow, Foodforecast and Orbisk; in supply and distribution at GrubMarket and Burnt; and in quality and safety inspection at Polysense and ART Technologies.

These applications don't necessarily promise new food. Some promise knowing how much to order, catching a quality defect, or cutting what ends up as waste. The report also highlights voice agents handling restaurant orders, and computer-vision-powered robotics inside kitchens and production lines — all pulled together by a clear pressure point: labor cost and availability, in a sector that runs on thin margins.

Our reading is that this shift broadens what food innovation means. The future doesn't only change when what we eat changes — it also changes when the resources and processes that get food to us change. That also explains some of these businesses' appeal: the technology maps cleanly onto an existing operational problem with a measurable outcome. That doesn't mean AI in ingredient development has disappeared; the report tracks it too, in fermentation-strain optimization and formulation development, within a smaller, more capital-intensive group.

Alternative Proteins Haven't Disappeared

This is where broad generalizations get misleading. Alternative-protein deal count held at 34 in Q2, unchanged from the prior quarter. Notable rounds included The Protein Brewery at $55.5 million and Planetary at $27.5 million — $83 million combined for the two companies.

Both are fermentation names, while plant-based and cultivated-protein rounds stayed smaller, per the report. That's not enough evidence to declare the category fully recovered — but it is enough to reject describing it as a single bloc that's lost investor interest. Alternative protein spans different technologies, different cost structures, and different paths to product and market.

These rounds show capital is still giving some companies the runway to keep building. What round size alone doesn't show is commercial-scale production success, cost competitiveness, or durable demand. Tracking the sector well means moving past "how much did the company raise?" toward a sharper question: what does this funding let it actually prove?

Exits Are Improving — Cautiously

On the exit side, the numbers look more encouraging at first glance: $1.9 billion across 44 transactions in H1 2026, already ahead of 2025's full-year total of $1.3 billion. But the IPO of China's Sunmi, a restaurant-technology hardware company valued at roughly $1.3 billion, explains most of that improvement. Deals like the $100 million acquisition of TouchBistro add other signals, without yet making the recovery broad-based.

The distinction matters: one large company successfully reaching the public markets proves an exit path exists — it doesn't mean that path is now open to every company. Similarly, some acquisitions, particularly in alternative protein, may reflect sector consolidation more than they prove strong investment returns, and many deal values remain undisclosed.

What Future Does This Movement Reveal?

The report doesn't sketch a single future for food — it sketches several tracks advancing at different speeds: more personalized nutrition, operations increasingly run on data and automation, fermentation technology that keeps attracting funding, and mature companies finding narrow exit windows. The thread connecting them is the growing importance of the path from technology to commercial business: who pays, what value do they get, and what does it take to deliver that at scale?

For building foodtech in Saudi Arabia, this reading offers a lens for evaluation — not a recipe for copying global funding trends. Deploying software to cut restaurant waste is a different exercise from localizing production of a food ingredient, and each requires proving its own case for feasibility.

The future of food isn't reduced to the flashiest technology, or the category that raised the most. But it is shaped by who gets the chance to test, scale, and reach market. That's why capital movement is worth reading as a signal of what's being built now — not a final verdict on everything that deserves to be built.

Source & Scope: PitchBook's H1 2026 Foodtech report, published August 27, 2026. This reading draws on the preview edition, in particular pages 4–6. Data through June 30, 2026. Interpretations tying the findings to the Saudi context are SFT's editorial reading, not local findings presented by the report itself.